Lilly loses to Actavis over Alimta in Germany
Reuters reported on March 6:
--
Eli Lilly has lost a patent case in Germany over its blockbuster Alimta lung cancer drug to generic producer Actavis, hitting the U.S. drugmaker's future sales hopes for the medicine.
--
--
Eli Lilly has lost a patent case in Germany over its blockbuster Alimta lung cancer drug to generic producer Actavis, hitting the U.S. drugmaker's future sales hopes for the medicine.
--
posted by Lawrence B. Ebert at 8:31 PM
0 Comments:
Post a Comment
<< Home